Theranostics 2022; 12(14):6155-6156. doi:10.7150/thno.77186 This issue

Erratum

Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum

Xun Sun1,2, Kexin Li1,2, Rongrong Zha1,2, Shengzhi Liu2, Yao Fan1,2, Di Wu1,2, Misato Hase2,3, Uma K. Aryal4, Chien-Chi Lin2,5, Bai-Yan Li1✉, Hiroki Yokota1,2,5,6✉

1. Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
2. Department of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA.
3. Graduate School of Engineering, Mie University, Mie 514, Japan.
4. Department of Comparative Pathobiology, Purdue University, West Lafayette, IN 47907, USA.
5. Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
6. Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Sun X, Li K, Zha R, Liu S, Fan Y, Wu D, Hase M, Aryal UK, Lin CC, Li BY, Yokota H. Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum. Theranostics 2022; 12(14):6155-6156. doi:10.7150/thno.77186. Available from https://www.thno.org/v12p6155.htm

File import instruction

Corrected-article in Theranostics, Volume 11, 5143